Cutaneous sarcoidosis by interferon therapy in a patient with melanoma.
Alonso-Pérez
A
A
Ballestero-Díez
M
M
Fraga
J
J
García-Díez
A
A
Fernández-Herrera
J
J
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006099:Granuloma / Q000139:chemically induced / Q000473:pathology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008545:Melanoma / Q000188:drug therapy*; D011994:Recombinant Proteins; D012507:Sarcoidosis / Q000139:chemically induced* / Q000473:pathology; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000188:drug therapy*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins